Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France

European Journal of Nutrition

Volumn 52, Issue 4, 2013, Pages 1289-1302

  Menaa, Farid ^a   Menaa, Abder ^b   Menaa, Bouzid ^a   Tréton, Jacques ^c  

^a Fluorotronics Inc   (United States)

^b Dept of Clinical Nutrition   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

French populations; Health complications; Nutrition; Preventive medicine; Regulatory affairs; Trans fatty acids

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN; CONJUGATED LINOLEIC ACID; ELAIDIC ACID; FATTY ACID ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLEIC ACID; PALMITIC ACID; SATURATED FATTY ACID; TRANS FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; UNSATURATED FATTY ACID; VACCENIC ACID;

ATHEROGENESIS; BREAST CANCER; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATALYSIS; COLORECTAL CANCER; DIET SUPPLEMENTATION; ENDOTHELIAL DYSFUNCTION; FAT INTAKE; FOOD INTAKE; FOOD PACKAGING; FRANCE; GOVERNMENT REGULATION; HEALTH HAZARD; HEAT TREATMENT; HUMAN; HYDROGENATION; INSULIN RESISTANCE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PREVENTIVE MEDICINE; REVIEW; TERATOGENICITY;

ANIMALS; CARDIOVASCULAR DISEASES; DIETARY FATS; DYSLIPIDEMIAS; FOOD HANDLING; FRANCE; GUIDELINES AS TOPIC; HEALTH PROMOTION; HUMANS; HYDROGENATION; LEGISLATION, FOOD; NUTRITION POLICY; RISK; RUMEN; RUMINANTS; TERMINOLOGY AS TOPIC; TRANS FATTY ACIDS;

EID: 84878527043     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-012-0484-4     Document Type: Review

References (157)

1. Brouwer IA, Wanders AJ, Katan MB (2010) Effect of animal and industrial trans fatty acids on HDL and LDL cholesterol levels in humans - a quantitative review. PLoS ONE 5:e9434
2. Sommerfeld M (1983) Trans unsaturated fatty acids in natural products and processed foods. Prog Lipid Res 22:221-233
3. Ledoux M, Rouzeau A, Sauvant D, Bas P (2002) Occurrence of trans-C18:1 fatty acid isomers in goat milk: effect of two dietary regimens. J Dairy Sci 85:190-197
4. Aro A, Antoine JM, Pizzoferrato L, Reykdal O, Van Poppel G (1998) Trans fatty acids in dairy and meat products from 14 European countries: the TRANSFAIR Study. J Food Compos Anal 11:150-160
5. Turpeinen AM, Mutanen M, Aro A, Salminen I, Basu S, Palmquist DL, Griinari JM (2002) Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76:504-510
6. Wolff RL, Combe NA, Destaillats F, Boué C, Precht D, Molkentin J, Entressangles B (2000) Follow-up of the D4 to D16 trans-18:1 isomer profile and content in French Processed foods containing partially hydrogenated vegetable oils during the period 1995-1999. Analytical and nutritional implications. Lipids 35:815-825
7. Ratnayake WM, Galli C (2009) Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann Nutr Metab 55:8-43
8. Saguy IS, Dana D (2003) Integrated approach to deep fat frying: engineering, nutrition, health and consumer aspects I. J Food Eng 56:3143-3152
9. Hulshof KF, van Erp-Baart MA, Anttolainen M, Becker W, Church SM, Couet C, Hermann-Kunz E, Kesteloot H, Leth T, Martins I, Moreiras O, Moschandreas J, Pizzoferrato L, Rimestad AH, Thorgeirsdottir H, van Amelsvoort JM, Aro A, Kafatos AG, Lanzmann-Petithory D, van Poppel G (1999) Intake of fatty acids in western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr 53:143-157
10. American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, Brands M, Carnethon M, Daniels S, Franch HA, Franklin B, Kris-Etherton P, Harris WS, Howard B, Karanja N, Lefevre M, Rudel L, Sacks F, Van Horn L, Winston M, Wylie-Rosett J (2006) Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 114:82-96
11. Ascherio A, Hennekens CH, Buring JE, Master C, Stampfer MJ, Willett WC (1994) Trans-fatty acids intake and risk of myocardial infarction. Circulation 89:94-101
12. Pietinen P, Ascherio A, Korhonen P, Hartman AM, Willett WC, Albanes D, Virtamo J (1997) Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol 145:876-887
13. Jakobsen MU, Overvad K, Dyerberg J, Heitmann BL (2008) Intake of ruminant trans fatty acids and risk of coronary heart disease. Int J Epidemiol 37:173-182
14. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH (1993) Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341:581-585
15. Oomen CM, Ocké MC, Feskens EJ, van Erp-Baart MA, Kok FJ, Kromhout D (2001) Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357:746-751
16. Thompson AK, Minihane AM, Williams CM (2011) Trans fatty acids and weight gain. Int J Obes (Lond) 35:315-324
17. Smith BK, Robinson LE, Nam R, Ma DW (2009) Trans-fatty acids and cancer: a mini-review. Br J Nutr 102:1254-1266
18. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354:1601-1613
19. Almendingen K, Jordal O, Kierulf P, Sandstad B, Pedersen JI (1995) Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. J Lipid Res 36:1370-1384
20. Müller H, Jordal O, Seljeflot I, Kierulf P, Kirkhus B, Ledsaak O, Pedersen JI (1998) Effect on plasma lipids and lipoproteins of replacing partially hydrogenated fish oil with vegetable fat in margarine. Br J Nutr 80:243-251
21. Vermunt SH, Beaufrère B, Riemersma RA, Sébédio JL, Chardigny JM, Mensink RP, TransLinE Study (2001) Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: the TransLinE Study. Br J Nutr 85:387-392
22. Bhattacharya A, Banu J, Rahman M, Causey J, Fernandes G (2006) Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17:789-810
23. Whigham LD, Watras AC, Schoeller DA (2007) Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. Am J Clin Nutr 85:1203-1211
24. World Health Organization (2004) Global strategy on diet, physical activity and health. WHO, Geneva
25. Nishida C, Uauy R, Kumanyika S, Shetty P (2004) The Joint WHO/FAO Expert Consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications. Public Health Nutr 7:245-250
26. PAHO/WHO Task Force (2007) Trans fats free Americas. Conclusions and Recommendations. Pan American Health Organization, Washington, DC
27. [No authors listed] (1978) The nomenclature of lipids (Recommendations 1976) IUPAC-IUB Commission on Biochemical nomenclature. Biochem J 171(1):21-35
28. Fahy E, Subramaniam S, Murphy RC, Nishijima M, Raetz CR, Shimizu T, Spener F, van Meer G, Wakelam MJ, Dennis EA (2009) Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res 50:S9-S14
29. Graber R, Sumida C, Nunez EA (1994) Fatty acids and cell signal transduction. J Lipid Mediat Cell Signal 9:91-116
30. Woollett LA, Spady DK, Dietschy JM (1992) Saturated and unsaturated fatty acids independently regulate low density lipoprotein receptor activity and production rate. J Lipid Res 33:77-88
31. Yaqoob P (2003) Fatty acids as gatekeepers of immune cell regulation. Trends Immunol 24:639-645
32. Neitzel JJ (2010) Fatty acid molecules: fundamentals and role in signaling. Nat Educ 3:57
33. Davidson BC, Cantrill RC (1985) Fatty acid nomenclature. A short review. S Afr Med J 67:633-634
34. Lobb K, Chow CK (2007) Fatty acid classification and nomenclature. In: Chow CK (ed) Fatty acids in foods and their health implications, 3rd edn. CRC Press, New York, pp 1-15
35. Holman RT (1998) The slow discovery of the importance of omega 3 essential fatty acids in human health. J Nutr 128:427S-433S
36. Holman RT (1964) Nutritional and metabolic interrelationships between fatty acids. Fed Proc 23:1062-1067
37. Sébédio JL (2007) Acides gras trans: nature, origine et impact sur la santé. Cah Nutr Diet 42:239-245
38. Dobson G (2002) Analysis of fatty acids in functional foods with emphasis on ω3 fatty acids and conjugated linoleic acid. In: Hurst WJ (ed) Methods of analysis for functional foods and nutraceuticals. CRC Press, New York
39. Handbook of Chemistry and Physics (2007) Section 7: Biochemistry. In: Taylor and Francis Group, LLC, 88th edn
40. Mosley EE, Wright AL, McGuire MK, McGuire MA (2005) Trans fatty acids in milk produced by women in the United States. Am J Clin Nutr 82:1292-1297
41. Kraft J, Hanske L, Möckel P, Zimmermann S, Härtl A, Kramer JK, Jahreis G (2006) The conversion efficiency of trans-11 and trans-12 18:1 by Delta9-desaturation differs in rats. J Nutr 136:1209-1214
42. Griinari JM, Corl BA, Lacy SH, Chouinard PY, Nurmela KVV, Bauman DE (2000) Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by D9-desaturase. J Nutr 130:2285-2291
43. Chilliard Y, Ferlay A, Doreau M (2001) Contrôle de la qualité nutritionnelle des matières grasses du lait par l'alimentation des vaches laitières: acides gras trans polyinsaturés, acide linoléique conjugué. INRA Prod Anim 14:323-335
44. Griinari JM, Bauman DE (1999) Biosynthesis of conjugated linoleic acid and its incorporation into meat and milk in ruminants. In: Yurawecz MP, Mossoba MM, Kramer JKG, Pariza MW, Nelson GJ (eds) Advances in conjugated linoleic acid research. AOCS Press, Champaign, pp 180-200
45. Precht D (1995) Variation of trans fatty acids in milk fats. Z Ernährungswiss 34:27-29
46. Ledoux M, Laloux L, Sauvant D (2000) Les isomères trans des acides gras: origine et présence dans l'alimentation. Sci Alim 20:393-411
47. Chilliard Y, Ferlay A, Rouel J, Lamberet G (2003) A review of nutritional and physiological factors affecting goat milk lipid synthesis and lipolysis. J Dairy Sci 86:1751-1770
48. Lucas A, Agabriel C, Martin B, Ferlay A, Verdier-Metz I, Coulon JB, Rock E (2006) Relationships between the conditions of cow's milk production and the contents of components of nutritional interest in raw milk farmhouse cheese. Lait 86:177-202
49. de Heredia FP, Larque E, Del Puy Portillo M, Canteras M, Zamora S, Garaulet M (2008) Age-related changes in fatty acids from different adipose depots in rat and their association with adiposity and insulin. Nutrition 24:1013-1022
50. Sabatier P (1966) The Nobel Prize in Chemistry 1912. Nobel Lectures, Chemistry, 1901-1921. Elsevier. Nobel Foundation http://www.nobelprize.org/ nobel-prizes/chemistry/laureates/1912/
51. Normann W (1903) Process for converting unsaturated fatty acids or their glycerides into saturated compounds. DE patent 141029 and GB patent 190301515
52. Perkins AG, Smick C (1987) Octadecatrienoic fatty acid isomers of partially hydrogenated soybean oil. J Am Oil Chem Soc 64:1150-1155
53. Brühl L (1995) Determination of trans fatty acids in cold pressed oils. Eur J Med Res 1:89-93
54. San Juan PMF (1996) Study of isomeric trans fatty acids content in the commercial Spanish food. Int J Food Sci Nutr 47:399-403
55. Precht D, Molkentin J (2000) Recent trends in the fatty acid composition of German sunflower margarines, shortenings and cooking fats with emphasis on individual C16:1, C18:1, C18:2, C18:3 and C20:1 trans isomers. Nahrung 44:222-228
56. Henninger M, Ulberth F (1996) Trans fatty acids in margarines and shortenings marketed in Austria. Z Lebensm Unters Forsch 203:210-215
57. Ackman RG, Mag TK (1998) Trans fatty acids and the potential for less in technical products. In: Sebedio JL, Christie WW (eds) Trans fatty acids in human nutrition. The Oily Press, Dundee, pp 35-58
58. Ratnayake WMN, Pelletier G, Hollywood R, Bacler S, Leyle D (1998) Trans fatty acids in Canadian margarines: recent trends. J Am Oil Chem Soc 75:1587-1594
59. Ackman RG, Hooper SN, Hooper DL (1974) Linolenic acid artefacts from the deodorization of oils. J Am Oil Chem Soc 51:42-49
60. Sébédio JL, Grandgirard A, Prevost J (1988) Linoleic acid isomers in heat treated sunflower oils. J Am Oil Chem Soc 65:362-366
61. Devinat G, Scamaroni L, Naudet M (1980) Isomerisation de l'acide linolenique durant la desodorisaton des huiles de colza et de soja. Rev Franç Corps Gras 27:283-287
62. Shantha NC, Ram LN, O'Leary J, Hicks CL, Decker EA (1995) Conjugated linoleic acid concentrations in dairy products as affected by processing and storage. J Food Sci 60:695-697
63. Rodríguez-Alcalá LM, García-Martínez MC, Cachón F, Marmesat S, Alonso L, Márquez-Ruiz G, Fontecha J (2007) Changes in the lipid composition of powdered infant formulas during long-term storage. J Agric Food Chem 55:6533-6538
64. Ratnayake WMN (2004) Overview of methods for the determination of trans fatty acids by gas chromatography, silver-ion thin-layer chromatography, silver-ion liquid chromatography, and gas chromatography/mass spectrometry. J AOAC Int 87:523-529
65. Ackman RG (2008) Application of gas-liquid chromatography to lipid separation and analysis: Qualitative and quantitative analysis. In: Chow CK (ed) Fatty acids in foods and their health implications. CRC Press, London, pp 47-65
66. Mossoba MM, Yurawecz MP, Delmonte P, Kramer KG (2004) Overview of infrared methodologies for trans fat determination. J AOAC Int 87:540-544
67. Ratnayake WMN, Hansen SL, Kennedy MP (2006) Evaluation of the CP-Sil 88 and SP-2560 GC columns used in the recently approved AOCS Official Method Ce 1 h-05: determination of cis-, trans-, saturated, monounsaturated and polyunsaturated fatty acids in vegetable or non-ruminant animal oils and fats by capillary GLC method. J Am Oil Chem Soc 83:475-488
68. AOCS official method Ce 1 h-05 (2005) Determination of cis-, trans-, saturated, monounsaturated and polyunsaturated fatty acids in vegetable or non-ruminant animal oils and fats by capillary GLC method. In: Official Methods and Recommended Practices of the AOCS, 5th edn. Urbana, American Oil Chemists' Society
69. AOAC Official Method 996.06 (2001). Fat (total, saturated, and unsaturated) in foods, hydrolytic extraction gas chromatographic method. In: Horwitz W (ed) Official Methods of Analysis of AOAC International, 18th edn. Gaithersburg, AOAC
70. Volatier JL, Verger P (1999) Recent national French food and nutrient intake data. Br J Nutr 81:S57-S59
71. Bertail P, Boizot C, Combris P (1993) La consommation alimentaire en 1991, distribution des quantités consommées à domicile, INRA ESR Ivry
72. Favier JC, Ireland-Ripert J, Toque C, Feinberg M (1996) Répertoire général des aliments, table de composition, CNEVA. CIQUAL. Tec & Doc Lavoisier, Paris
73. Thiebaut AC, Clavel-Chapelon F (2001) Fat consumption and breast cancer: preliminary results from the E3NEpic cohort. Bull Cancer 88:954-958
74. Combe N, Boue C, Entressangles B (2000) Consumption of trans fatty acids and cardiovascular risks: aquitaine survey (France). Oléagineux Corps gras Lipides 7:30-34
75. AFSSA (Agence Française de Sécurité Sanitaire des Aliments) (2005) Risques et bénéfices pour la santé des acides gras trans apportés par les aliments. Recommandations (Rapport), p 217
76. AFSSA (Agence Française de Sécurité Sanitaire des Aliments). http://www.anses.fr/
77. AFSSA (Agence Française de Sécurité Sanitaire des Aliments) (2009) Avis de l'Agence française de sécurité sanitaire des aliments sur l′estimation des apports em acides grãs trans de la population française. Saisine n 2007-SA-0220
78. Rigaud D, Giachetti I, Deheeger M, Borys JM, Volatier JL, Lemoine A, Cassuto DA (1997) Enquête française de consommation alimentaire I. Energie Macro-nutr Cah Nutr Diét 32:379-389
79. Boué C, Combe N, Billeaud C, Mignerot C, Entressangles B, Thery G, Geoffrion H, Brun JL, Dallay D, Leng JJ (2000) Trans fatty acids in adipose tissue of French women in relation to their dietary sources. Lipids 35:561-566
80. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL (2006) Global burden of disease and risk factors. The World Bank and Oxford University Press, Oxford, p 469
81. Steinberg D, Gotto AM Jr (1999) Preventing coronary artery disease by lowering cholesterol levels: fifty years from bench to bedside. JAMA 282:2043-2050
82. Genest J Jr, Cohn JS (1999) Epidemiological evidence linking plasma lipoprotein disorders to atherosclerosis and other diseases. In: Barter PJ, Rye KA (eds) Plasma Lipids and their role in disease. Taylor and Francis, London, pp 46-48
83. Hodis NN, Mack WJ (1998) Triglyceride-rich lipoproteins and progression of atherosclerosis. Eur Heart J 19:40-44
84. Chapman MJ (1999) Atherogenicity of low density lipoprotein: mechanisms. In: Barter PJ, Rye KA (eds) Plasma lipids and their role in disease. Taylor and Francis, London
85. de Lorgeril M (2008) Cholestérol, mensonges et propagande. Thierry Souccar Editions, p 317
86. Ravnskov U (2000) The cholesterol myths. New Trends Publishing, Washington, DC
87. Bassett CM, McCullough RS, Edel AL, Maddaford TG, Dibrov E, Blackwood DP, Austria JA, Pierce GN (2009) Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism 58:1802-1808
88. McColl MD, Sattar N, Ellison J, Tait RC, Walker ID, Packard CJ, Greer IA (2000) Lipoprotein (a), cholesterol and triglycerides in women with venous thromboembolism. Blood Coagul Fibrinolysis 11:225-229
89. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407-413
90. Loscalzo J (1990) Lipoprotein(a). A unique risk factor for atherothrombotic disease. Arteriosclerosis 10:672-679
91. Kohler HP, Grant PJ (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 342:1792-1801
92. Junker R, Heinrich J, Schulte H, van de Loo J, Assmann G (1997) Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 17:1539-1544
93. Mozaffarian D, Aro A, Willett WC (2009) Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 63:S5-S21
94. Ascherio P, Rimm EB, Giovannucci EL, Spiegleman D, Stampfer M, Willett WC (1996) Dietery fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 313:84-90
95. Hu FB, Stampfer MJ, Manson JAE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC (1997) Dietary Fat Intake and the Risk of Coronary Heart Disease in Women. N Engl J Med 337:1491-1499
96. Aro A, Kardinaal AF, Salminen I, Kark JD, Riemersma RA, Delgado-Rodriguez M, Gomez-Aracena J, Huttunen JK, Kohlmeier L, Martin BC et al (1995) Adipose tissue isomeric trans fatty acids and risk of myocardial infarction in nine countries: the EURAMIC study. Lancet 345:273-278
97. Kromhout D, Menotti A, Bloemberg B, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Giampaoli S, Jansen A et al (1995) Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 24:308-315
98. Chardigny JM, Chardigny JM, Destaillats F, Malpuech-Brugère C, Moulin J, Bauman DE, Lock AL, Barbano DM, Mensink RP, Bezelgues JB, Chaumont P, Combe N, Cristiani I, Joffre F, German JB, Dionisi F, Boirie Y, Sébédio JL (2008) Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 87:558-566
99. Motard-Bélanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B (2008) Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 87:593-599
100. Roberts TL, Wood DA, Riemersma RA, Gallagher PJ, Lampe FC (1995) Trans isomers of oleic and linoleic acids in adipose tissue and sudden cardiac death. Lancet 345:278-282
101. Van de Vijver LP, van Poppel G, van Houwelingen A, Kruyssen DA, Hornstra G (1996) Trans unsaturated fatty acids in plasma phospholipids and coronary heart disease: a case-control study. Atherosclerosis 126:155-161
102. Fritsche J, Steinhart H, Kardalinos V, Klose G (1998) Contents of trans-fatty acids in human substernal adipose tissue and plasma lipids: relation to angiographically documented coronary heart disease. Eur J Med Res 3:401-416
103. Van de Vijver LP, Kardinaal AF, Couet C, Aro A, Kafatos A, Steingrimsdottir L, Amorim Cruz JA, Moreiras O, Becker W, van Amelsvoort JM, Vidal-Jessel S, Salminen I, Moschandreas J, Sigfússon N, Martins I, Carbajal A, Ytterfors A, Poppel G (2000) Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur J Clin Nutr 54:126-135
104. Abbey M, Nestel PJ (1994) Plasma cholesteryl ester transfer activity is increased when trans-elaidic acid is substituted for cis-oleic acid in diet. Atherosclerosis 106:99-107
105. Van Tol A, Zock PL, Van Gent T, Scheek LM, Katan MB (1995) Dietary trans fatty acids increase serum cholesteryl ester transfer protein activity in man. Atherosclerosis 115:129-134
106. Mensink R, Katan MB (1990) Effect of dietary trans fatty acids on high density and low density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 323:439-445
107. Zock PL, Katan MB (1992) Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in human. J Lipid Res 33:399-410
108. Judd JT, Clevidence BA, Muesing RA, Wittes J, Sunkin ME, Podczasy JJ (1994) Dietary trans fatty acids: effects on plasma and lipoproteins of healthy men and women. Am J Clin Nutr 59:861-868
109. Katan MB, Zock PL, Mensink RP (1995) Trans fatty acids and their effects on lipoproteins in humans. Annu Rev Nutr 15:473-493
110. Harvey KA, Arnold T, Rasool T, Antalis C, Miller SJ, Siddiqui RA (2008) Trans-fatty acids induce pro-inflammatory responses and endothelial cell dysfunction. Br J Nutr 99:723-731
111. Mozaffarian D (2006) Trans fatty acids - effects on systemic inflammation and endothelial function. Atheroscler Suppl 7:29-32
112. Risérus U (2006) Trans fatty acids, insulin sensitivity and type 2 diabetes. Scand J Food Nutr 50:161-165
113. Micha R, Mozaffarian D (2009) Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 5:335-344
114. Dorfman SE, Laurent D, Gounarides JS, Li X, Mullarkey TL, Rocheford EC, Sari-Sarraf F, Hirsch EA, Hughes TE, Commerford SR (2009) Metabolic implications of dietary trans-fatty acids. Obesity (Silver Spring) 17:1200-1207
115. Riserus U, Arner P, Brismar K, Vessby B (2002) Treatment with dietary trans 10 cis 12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25:1516-1522
116. Saravanan N, Haseeb A, Ehtesham NZ, Ghafoorunissa AS (2005) Differential effects of dietary saturated and trans fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur J Endocrinol 153:159-165
117. Taylor CG, Zahradka P (2004) Dietary conjugated linoleic acid and insulin sensitivity and resistance in rodent models. Am J Clin Nutr 79:1164S-1168S
118. Gaullier JM, Halse J, Hoye K, Kristiansen K, Fagerteun H, Vik H, Gudmundsen O (2004) Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 79:1118-1125
119. Malpuech-Brugère C, Verboeket-van de Venne WP, Mensink RP, Arnal MA, Morio B, Brandolini M, Saebo A, Lassel TS, Chardigny JM, Sébédio JL, Beaufrère B (2004) Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 12:591-598
120. Bakker N, Van't Veer P, Zock PL, The EURAMIC Study Group (1997) Adipose fatty acids and cancers of the breast, prostate and colon: an ecological study. Int J Cancer 72:587-591
121. Chajès V, Thiébaut AC, Rotival M, Gauthier E, Maillard V, Boutron-Ruault MC, Joulin V, Lenoir GM, Clavel-Chapelon F (2008) Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 167:1312-1320
122. Slattery ML, Benson J, Ma KN, Potter JD (2001) Trans-fatty acids and colon cancer. Nutr Cancer 39:170-175
123. Limburg PJ, Liu-Mares W, Vierkant RA, Wang AH, Harnack L, Flood AP, Sellers TA, Cerhan JR (2008) Prospective evaluation of trans-fatty acid intake and colorectal cancer risk in the Iowa Women's Health Study. Int J Cancer 123:2717-2719
124. Byrne C, Rockett H, Holmes MD (2002) Dietary fat, fat subtypes, and breast cancer risk: lack of an association among postmenopausal women with no history of benign breast disease. Cancer Epidemiol Biomarkers Prev 11:261-265
125. Tanmahasamut P, Liu J, Hendry LB, Sidell N (2004) Conjugated linoleic acid block estrogen signalling in human breast cancer cells. J Nutr 134:674-680
126. Corl BA, Barbano DM, Bauman DE, Ip C (2003) cis-9, trans-11 CLA derived endogenously from trans-11 18:1 reduces cancer risk in rats. J Nutr 33:2893-2900
127. Degen C, Ecker J, Piegholdt S, Liebisch G, Schmitz G, Jahreis G (2011) Metabolic and growth inhibitory effects of conjugated fatty acids in the cell line HT-29 with special regard to the conversion of t11, t13-CLA. Biochim Biophys Acta 1811(12):1070-1080
128. Koletzko B, Thiel I, Springer S (1992) Lipids in human milk: a model for infant formulae? Eur J Clin Nutr 46:S45-S55
129. Carlson SE, Clandinin MT, Cook HW, Emken EA, Filer LJ Jr (1997) Trans fatty acids: infant and fetal development. Am J Clin Nutr 66:715S-736S
130. Combe N, Judde A, Billeaud C, Boue C, Turon F, Entressangles B, Dallay D, Lengh JJ (1998) Distribution of dietary trans isomers of essential fatty acids in blood lipid classes. In: Riemersma RA, Armstrong RA, Kelly RW, Wilson R (eds) Proceedings of the fourth international congress on essential fatty acids and eicosanoids. Champaign, AOCS Press, pp 239-242
131. Boué C, Combe N, Billeaud C, Entressangles B (2001) Nutritional implications of trans fatty acids during perinatal period, in French pregnant women. Lipids, fats and oils: opportunities and responsibilities in the New Century. OCL 8:68-72
132. Bouwstra H, Dijck-Brouwer J, Decsi T, Boehm G, Boersma ER, Muskiet FA, Hadders-Algra M (2006) Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids. Pediatr Res 60:334-339
133. Innis SM (2007) Fatty acids and early human development. Early Hum Dev 83:761-766
134. Innis SM (2006) Trans fatty intakes during pregnancy, infancy and early childhood. Atheroscler Suppl 7:17-20
135. Pérez-Ferrer C, Lock K, Riviera JÁ (2010) Learning from international policies on trans fatty acids to reduce cardiovascular disease in low- and middle-income countries, using Mexico as a case study. Health Policy Plan 25:39-49
136. Stender S, Dyerberg J (2004) Influence of trans fatty acids on health. Ann Nutr Metab 48:61-66
137. Stender S, Dyerberg J, Hølmer G, Ovesen L, Sandström B (1995) The influence of trans fatty acids on health: a report from the Danish Nutrition Council. Clin Sci (Lond) 88:375-392
138. Leth T, Jensen HG, Mikkelsen AA, Bysted A (2006) The effect of the regulation on trans-fatty acid content in Danish food. Atherosclerosis S7:53-56
139. L'Abbé MR, Stender S, Skeaff CM, Ghafoorunissa, Tavella M (2009) Approaches to removing trans fats from the food supply in industrialized and developing countries. Eur J Clin Nutr 63:S50-S67
140. Okie S (2007) New York to trans fats: you're out! N Engl J Med 356:2017-2021
141. Leake LL (2007) Trans fat to go. Food Technol 61:66-68
142. California State Assembly (2008) Assembly Bill No. 97. Sacramento, CA
143. Trans Fat Task Force (2006) Ottawa: Health Canada and Heart and Stroke Foundation of Canada; TRANSforming the Food Supply, Report of the Trans Fat Task Force submitted to the Minister of Health of Canada
144. CSPINET (Center for Science in the Public Interest). http://www.cspinet. org/
145. Moss J (2006) Labeling of trans fatty acid content in food, regulations and limits-the FDA view. Atheroscler Suppl 7:57-59
146. Tarrago-Trani MT, Phillips KM, Lemar LE, Holden JM (2006) New and existing oils and fats used in products with reduced trans-fatty acid content. J Am Diet Assoc 106:867-880
147. Coutinho JG, Recine E (2007) International experiences with health claims in food labeling. Rev Panam Salud Publica 22:432-437
148. Valenzuela A, Nieto S, Peterson G, Tavella M (2004) Comparative study in fried food about the stability of different vegetable oils. Fat Oils Mag 2:22-28
149. Korver O, Katan MB (2006) The elimination of trans fats from spreads: how science helped to turn an industry around. Nutr Rev 64:275-279
150. Willett WC, Ascherio A (1994) Trans fatty acids: are the effects only marginal? Am J Public Health 84:722-724
151. Katan MB (2006) Regulation of trans fats: the gap, the Polder, and McDonald's French fries. Atheroscler Suppl 7:63-66
152. Food Standards Agency (2007) FSA Board to advise the Department of Heath to maintain successful voluntary approach for trans fats in food. Press release, London
153. Willett WC (2006) The scientific basis for TFA regulations-is it sufficient? Comments from the USA. Atheroscler Suppl 7:69-71
154. Colo'n Ramos U, Baylin A, Campos H (2006) The relation between trans fatty acid levels and increased risk of myocardial infarction does not hold at lower levels of trans fatty acids in Costa Rican food supply. J Nutr 136:2887-2892
155. Baylin A, Kabagambe EK, Ascherio A, Spiegelman D, Campos H (2003) High 18:2 trans-fatty acids in adipose tissue are associated with increased risk of nonfatal acute myocardial infarction in Costa Rican adults. J Nutr 133:1186-1191
156. The LIPID MAPS-Nature Lipidomics Gateway, http://www.lipidmaps.org/
157. Fahy E, Sud M, Cotter D, Subramaniam S (2007) LIPID MAPS online tools for lipid research. Nucleic Acids Res 35:W606-W612